CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
Bionic Pancreas +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02092220
NCT02092220N/ACompleted
CompareCT.gov

A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas

Massachusetts General Hospital·interventional·Posted Mar 20, 2014·Updated Nov 22, 2017

In Brief

A clinical study evaluating Bionic Pancreas and Insulin pump with or without CGM for Diabetes Mellitus Type 1. Completed, enrolled 48 participants across 4 sites.

Detailed Summary

This study will test the hypothesis that a wearable bionic pancreas system that automatically delivers insulin and glucagon can provide superior regulation of glycemia versus usual care for adults with type 1 diabetes. Please note that all participants must work or attend school at one of the following campuses: Massachusetts General Hospital in Boston, MA; University of Massachusetts Medical Center in Worcester, MA; University of North Carolina in Chapel Hill, NC; Stanford University in Palo Alto, CA.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus Type 1
CountriesUnited States
CollaboratorsBoston University

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 20, 2014
Enrollment StartApr 1, 2014
Primary CompletionJul 1, 2015
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.3 years ago

Interventions

Bionic Pancreasdevice

Insulin pump with or without CGMdevice